Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950142-24-001419
Filing Date
2024-05-24
Accepted
2024-05-24 16:44:51
Documents
1
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es240464226_3-inhibrx.html 3  
1 OWNERSHIP DOCUMENT es240464226_3-inhibrx.xml 3 2176
  Complete submission text file 0000950142-24-001419.txt   4064
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Reporting) CIK: 0001739614 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42031 | Film No.: 24985147
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)